IL141501A0 - Alginate capsules for use in the treatment of brain tumour - Google Patents

Alginate capsules for use in the treatment of brain tumour

Info

Publication number
IL141501A0
IL141501A0 IL14150199A IL14150199A IL141501A0 IL 141501 A0 IL141501 A0 IL 141501A0 IL 14150199 A IL14150199 A IL 14150199A IL 14150199 A IL14150199 A IL 14150199A IL 141501 A0 IL141501 A0 IL 141501A0
Authority
IL
Israel
Prior art keywords
treatment
brain tumour
alginate capsules
alginate
capsules
Prior art date
Application number
IL14150199A
Other languages
English (en)
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Publication of IL141501A0 publication Critical patent/IL141501A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14150199A 1998-08-26 1999-08-25 Alginate capsules for use in the treatment of brain tumour IL141501A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO983911A NO983911D0 (no) 1998-08-26 1998-08-26 Alginatkapsler til bruk ved behandling av hjernesvulst
PCT/NO1999/000266 WO2000012066A1 (en) 1998-08-26 1999-08-25 Alginate capsules for use in the treatment of brain tumour

Publications (1)

Publication Number Publication Date
IL141501A0 true IL141501A0 (en) 2002-03-10

Family

ID=19902361

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14150199A IL141501A0 (en) 1998-08-26 1999-08-25 Alginate capsules for use in the treatment of brain tumour
IL141501A IL141501A (en) 1998-08-26 2001-02-19 Alginate capsules for use in the treatment of brain tumors

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141501A IL141501A (en) 1998-08-26 2001-02-19 Alginate capsules for use in the treatment of brain tumors

Country Status (16)

Country Link
US (2) US6926888B1 (xx)
EP (1) EP1105100A1 (xx)
JP (1) JP2002523445A (xx)
KR (1) KR100699286B1 (xx)
CN (1) CN1191823C (xx)
AU (1) AU760433B2 (xx)
BR (1) BR9913326A (xx)
CA (1) CA2340325A1 (xx)
IL (2) IL141501A0 (xx)
IS (1) IS5855A (xx)
NO (2) NO983911D0 (xx)
NZ (1) NZ510167A (xx)
RU (1) RU2229287C2 (xx)
TR (1) TR200100583T2 (xx)
WO (1) WO2000012066A1 (xx)
ZA (1) ZA200101464B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2313199A (en) * 1998-02-03 1999-08-23 Center For Disease Control And Prevention Recombinant lipidated psaa protein, methods of preparation and use
SE530184C2 (sv) * 2005-12-23 2008-03-18 Kjell Stenberg Bioadhesiv farmaceutisk filmkomposition innehållande lågviskösa alginater
KR100969516B1 (ko) * 2007-08-16 2010-07-09 경북대학교 산학협력단 세포 생존력 및 기능을 향상시키는 도우넛형 세포 캡슐의제조 방법 및 세포 치료적용
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5073491A (en) * 1988-12-23 1991-12-17 Hoffman-La Roche Inc. Immobilization of cells in alginate beads containing cavities for growth of cells in airlift bioreactors
US5459054A (en) * 1989-12-05 1995-10-17 Neocrin Company Cells encapsulated in alginate containing a high content of a- l- guluronic acid
US5166137A (en) 1991-03-27 1992-11-24 Nobipols Forskningsstiftelse Guluronic acid polymers and use of same for inhibition of cytokine production
DK0585368T3 (da) 1991-04-25 1998-03-16 Univ Brown Res Found Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
EP0769932B1 (en) 1994-07-08 1998-10-14 Baxter International Inc. Implanted device containing tumor cells for the treatment of cancer
US6126936A (en) 1995-03-10 2000-10-03 Biohybrid Technologies Llc Microcapsules and composite microreactors for immunoisolation of cells
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
DE69725317T2 (de) 1996-04-03 2004-07-29 The Rogosin Institute Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung
AU2674097A (en) 1996-04-17 1997-11-07 Cytotherapeutics, Inc. Method and device for delivery of apoptosis-inducing molecules
US6027721A (en) 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
DE19638745C2 (de) * 1996-09-11 2001-05-10 Schering Ag Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR)
US6368612B1 (en) * 1997-12-12 2002-04-09 Biohybrid Technologies Llc Devices for cloaking transplanted cells

Also Published As

Publication number Publication date
NZ510167A (en) 2003-09-26
ZA200101464B (en) 2002-05-21
NO20010960L (no) 2001-04-25
EP1105100A1 (en) 2001-06-13
AU760433B2 (en) 2003-05-15
US20050180960A1 (en) 2005-08-18
IL141501A (en) 2006-10-31
NO20010960D0 (no) 2001-02-26
US6926888B1 (en) 2005-08-09
CA2340325A1 (en) 2000-03-09
KR20010074851A (ko) 2001-08-09
WO2000012066A1 (en) 2000-03-09
AU5538999A (en) 2000-03-21
CN1191823C (zh) 2005-03-09
BR9913326A (pt) 2001-05-15
IS5855A (is) 2001-02-22
RU2229287C2 (ru) 2004-05-27
JP2002523445A (ja) 2002-07-30
TR200100583T2 (tr) 2001-06-21
NO983911D0 (no) 1998-08-26
KR100699286B1 (ko) 2007-03-26
CN1320032A (zh) 2001-10-31

Similar Documents

Publication Publication Date Title
HUP0102793A3 (en) Quinazolines for treating brain tumor and medicaments containing them
AU3673499A (en) Hydrogel for the therapeutic treatment of aneurysms
ZA957483B (en) Compounds and methods for the treatment of cancer
GB9824436D0 (en) Methods of treatment
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
ZA982968B (en) Compositions and methods for the treatment and diagnosis of breast cancer
SI1716853T1 (sl) Zdravljenje rakov äśloveĺ kega telesa z uporabo et743
HK1041827B (zh) 用於治療雌激素依賴性疾病的化合物以及製備和使用上述化合物的方法
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL143212A0 (en) Compositions and methods for the treatment of tumor
HUP0101947A3 (en) Combination for the treatment of tumors
IL141501A0 (en) Alginate capsules for use in the treatment of brain tumour
GB9812550D0 (en) Tumour therapy and imaging
IL150202A0 (en) Method and composition for the treatment of pain
GB2341099B (en) Clinical table for treatment of the spine
GB0020261D0 (en) Therapeutic treatment
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
GB2341314B (en) Medical patient suspension apparatus
AU2420201A (en) Compounds and methods for the treatment of pain
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
KR100512820B1 (en) Compositions and Methods for the Treatment of Tumor
KR100526723B1 (en) Compositions and Methods for the Treatment of Tumor
TW381479U (en) Improvement of the health bed for physical therapy
GB9716289D0 (en) Tumour treatment
GB9826888D0 (en) Cervical cancer treatment

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed